NEFL and Alzheimer disease: In fact, several recent studies have shown that serum or plasma NfL are direct indicators of axonal degeneration based on neuroimaging markers, including gray and white matter pathology [21, 40, 41], and can act as a proxy for hypometabolism in AD-vulnerable brain regions, particularly in Aβ-positive individuals [42].